Physician profile
Amit Chopra
NPI 1639157209
$1,301.96
in general payments reported to CMS, 2019-2025
7 companies · $155 in 2025
The $155 reported for 2025 was more than what 76% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $78.85 · 2021: $125 · 2022: $354 · 2023: $247 · 2024: $240 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $566.53 | 2022-2025 | Fisher & Paykel Healthcare |
| Portola Pharmaceuticals, LLC | $181.10 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Baudax Bio INC. | $124.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $120.50 | 2023 | Andexxa |
| E.R. Squibb & Sons, L.L.C. | $94.50 | 2022 | |
| Janssen Biotech, INC. | $90.30 | 2024 | Tecvayli, Darzalex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.